Starpharma Holdings Ltd

0.7661+0.0044+0.58%Vol 2.00K1Y Perf -21.83%
Nov 30th, 2021 12:40
BID0.0000 ASK0.0000
Open0.7504 Previous Close0.7617
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★     56.09
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
2.10 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha0.01 Standard Deviation0.16
Beta0.98 

Today's Price Range

0.75040.7661

52W Range

0.74411.7900

5 Year PE Ratio Range

-31.30074.900

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
0.58%
1 Month
-7.70%
3 Months
-19.61%
6 Months
-43.25%
1 Year
-21.83%
3 Years
-24.42%
5 Years
40.57%
10 Years
0.00%

TickerPriceChg.Chg.%
SPHRF0.76610.00440.58
AAPL161.84-1.9200-1.17
GOOG2 850.41-25.1200-0.87
MSFT323.01-6.4800-1.97
XOM60.89-0.3900-0.64
WFC47.75-1.1600-2.37
JNJ159.382.29001.46
FB306.84-3.5500-1.14
GE92.77-2.4600-2.58
JPM158.29-2.9200-1.81
Financial StrengthValueIndustryS&P 500US Markets
6.60
6.80
0.01
0.02
-
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
56.00
-1 863.80
-1 863.80
-596.50
-
RevenueValueIndustryS&P 500US Markets
1.29M
0.00
-8.21
-5.92
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2.00K
Shares Outstanding0
Shares Float406.68M
Trades Count2
Dollar Volume1.52K
Avg. Volume4.30K
Avg. Weekly Volume4.82K
Avg. Monthly Volume6.75K
Avg. Quarterly Volume6.47K
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating-
0.00
-
0.00
-
0.00

Starpharma Holdings Ltd

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialisation of dendrimer products for a pharmaceutical, life-science and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis, and as a condom coating.

CEO:

Telephone: +61 385322700

Address: 4-6 Southampton Crescent, Melbourne 3067, VIC, AUS

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

43%57%

Bearish Bullish

60%40%

News